Telangana attracts limelight at Bio International Convention Centre
HYDERABAD: Telangana continues to hog the limelight for the second consecutive day at the Bio International convention in the United States of America.
Telangana has been getting a lot of focus from investors the world over with the launch of the TS-iPASS last week. Industrialists and Investors are expressing interest to invest in Telangana in the coming months. The number of visitors to the convention is increasing, and in the India Pavilion, Telangana continues to be the major draw.
Telangana State Minister for Industries and Commerce, Textiles, Handlooms and Sugar, Jupally Krishna Rao today inaugurated the India pavilion at the BIO international convention, Philadelphia, USA.
BIO Exhibition-2015 featured more than 1,700 exhibitors and 60+ states, regional and country pavilions. “India Pavilion” focussed on the Government of India’s, Make-in-India (depicting Make, Develop and Innovate in India) to provide major thrust in the Biotechnology sector with participation from reputed Biotechnology, Pharmaceutical and Agri-Biotechnology Companies, allied industries, Government bodies, State Governments, Indian institutions and academia.
Minister has also inaugurated Telangana stall which attracted more investors than any other country at the Convention. And for announcing of new industrial policy Minister has visited and interacted with Canada, Korea, Mexico, Russia, and other stalls.
After that Krishna Rao participated in Indo-US bilateral trade meeting, where US and Indian represenatatives of trade were present, Kiran Majumdar, MD Biocon, India chaired the meeting.
The forum applauded to the new industrial policy of Telangana which is announced recently, the delegates have requested the government to liberalise clinic trials policies in which billions of dollars of business is existing and the meeting also requested to implement Ranjit Roy Chowdary committee report for clinical trials in India. Minister held talks with Pfizer, Merck, GlaxoSmithKline and other leading companies.
Talking on this occasion, Krishna Rao said, “I feel happy to share that, our Country i.e., India, had been able to successfully position its Biotech Industry in the world to capitalize on the unfolding global biologics opportunity by attracting talent with advanced technical skill-sets. Telangana has a dominant position in biotech, bulk drugs and pharmaceutical sector, and life sciences as an important sector in our State”.
”It is the commitment of our Policy to fast-track the development of industrial units. Every entrepreneur is our VIP. All Mega Projects will be given all permissions within 15 days. Apart from this, there is a galore of incentives, subsidies and reimbursements of taxes and tariffs. Transparency and accountability are our watchwords. Biotech and Pharma our thrust areas” he added.
While inviting the global participants to consider opening manufacturing and research facilities in Hyderabad, he mentioned that the government will unroll the red carpet and demonstrate that doing business with Telangana will be a matter of delight. He also launched the report titled “India Biotech Handbook 2015”.
Minister along with Pradeep Chandra, IAS, Special Chief Secretary (Finance), Government of Telangana, Shakthi Nagappan, CEO, BioAsia also participated in the US-India Bilateral Discussions focused on strengthening the US – India business relationship, which witnessed participation from about 50 companies from US and India. Holly Vineyard, Deputy Assistant Secretary for Asia, International Trade Administration, U.S. Department of Commerce addressed participants and was very appreciative of the radically new industrial policy of Telangana.
During the course of the day, the delegation also met several industrial leaders and multinational companies to attract investments into the State.
Some of the prominent meetings included: Pfizer represented by Justin McCarthy, senior vice president of Global Policy and International Public Affairs, Jeffrey Hamilton, senior director of Asia Pacific Public Affairs and Ms. Claudia Poteet, director, International Government Relations.
Impressed with the industrial policy, the Pfizer team expressed keen interest to explore opportunities to expand its vaccines business in the State in addition to working with the State Government on initiatives focused on promoting healthcare innovations. They responded positively about establishing a facility in Hyderabad, and to support for research and innovation in Telangana educational institutions, to provide vaccines to Telangana people for lowest rates.
The delegation had a very productive meeting with the emerging markets team of Merck & Co consisting of Jeffrey A. May, vice president, Global Public Affairs, Jeffrey Jemprecos, executive director and KG Anantha Krishnan, MD, India. The Merck team was excited about the new direction and approach of the State Government in encouraging businesses.
The delegation also met Rogerio Ribeiro, SVP and Area Head Emerging Markets & Australasia, Hasit Joshipura, senior vice president South Asia & General Manager, India and Shira Kilcoyne, director, Government Affairs, Emerging Markets & Asia Pacific from GSK and invited them to be a part of Telangana’s continuing growth story. (NSS)